{"entity":{"type":"insider","cik":"0001314575","url":"/insider/0001314575","json_url":"/insider/0001314575.json","name":"Beer Marc D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":45,"n_filings":21,"first":"2010-10-27","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Beer Marc D","source":"filing","n_filings":21,"first_seen":"2010-10-27","last_seen":"2026-08-12"}],"transactions":[{"id":9283474,"accession":"0001314575-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001314575-26-000007","line_url":"/filing/0001314575-26-000007#line-2","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"biote Corp.","issuer_ticker":"BTMD","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16000.0,"shares_display":"16,000","price_per_share":1.55,"price_display":"1.55","price_state":"stated","total_value":24800.0,"total_display":"24,800.00","total_whole":"24,800","shares_owned_after":239744.0,"shares_owned_after_display":"239,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-11","filed_date":"2026-08-12","scope":"insider"},{"id":9283475,"accession":"0001314575-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001314575-26-000007","line_url":"/filing/0001314575-26-000007#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"biote Corp.","issuer_ticker":"BTMD","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":115950.0,"shares_display":"115,950","price_per_share":1.53,"price_display":"1.53","price_state":"stated","total_value":177403.5,"total_display":"177,403.50","total_whole":"177,404","shares_owned_after":223744.0,"shares_owned_after_display":"223,744","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":4952020,"accession":"0001415889-25-008527","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-008527","line_url":"/filing/0001415889-25-008527#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"biote Corp.","issuer_ticker":"BTMD","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":107794.0,"shares_display":"107,794","price_per_share":3.87,"price_display":"3.87","price_state":"stated","total_value":417162.78,"total_display":"417,162.78","total_whole":"417,163","shares_owned_after":107794.0,"shares_owned_after_display":"107,794","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-17","filed_date":"2025-03-18","scope":"insider"},{"id":8247563,"accession":"0001209191-23-002786","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-002786","line_url":"/filing/0001209191-23-002786#line-3","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"biote Corp.","issuer_ticker":"BTMD","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":865384.0,"shares_display":"865,384","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":2596152.0,"total_display":"2,596,152.00","total_whole":"2,596,152","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":5317613,"accession":"0001209191-17-021902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-021902","line_url":"/filing/0001209191-17-021902#line-2","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":7.89,"price_display":"7.89","price_state":"stated","total_value":197250.0,"total_display":"197,250.00","total_whole":"197,250","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-20","filed_date":"2017-03-21","scope":"insider"},{"id":5317608,"accession":"0001209191-17-021902","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-021902","line_url":"/filing/0001209191-17-021902#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Minerva Neurosciences, Inc.","issuer_ticker":"NERV","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":8.34,"price_display":"8.34","price_state":"stated","total_value":208500.0,"total_display":"208,500.00","total_whole":"208,500","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-17","filed_date":"2017-03-21","scope":"insider"},{"id":6267236,"accession":"0001209191-14-049691","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-049691","line_url":"/filing/0001209191-14-049691","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":33.6539,"price_display":"33.65","price_state":"stated","total_value":336539.0,"total_display":"336,539.00","total_whole":"336,539","shares_owned_after":77100.0,"shares_owned_after_display":"77,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2014-07-31","scope":"insider","n_lines":2},{"id":6797725,"accession":"0001209191-14-038892","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-038892","line_url":"/filing/0001209191-14-038892#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":30.12,"price_display":"30.12","price_state":"stated","total_value":301200.0,"total_display":"301,200.00","total_whole":"301,200","shares_owned_after":69400.0,"shares_owned_after_display":"69,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-03","filed_date":"2014-06-04","scope":"insider"},{"id":6592083,"accession":"0001209191-14-036938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-036938","line_url":"/filing/0001209191-14-036938#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":31.59,"price_display":"31.59","price_state":"stated","total_value":315900.0,"total_display":"315,900.00","total_whole":"315,900","shares_owned_after":59400.0,"shares_owned_after_display":"59,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-27","filed_date":"2014-05-27","scope":"insider"},{"id":6911522,"accession":"0001209191-14-035717","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-035717","line_url":"/filing/0001209191-14-035717#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":30.53,"price_display":"30.53","price_state":"stated","total_value":305300.0,"total_display":"305,300.00","total_whole":"305,300","shares_owned_after":43000.0,"shares_owned_after_display":"43,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-20","filed_date":"2014-05-21","scope":"insider"},{"id":6911279,"accession":"0001209191-14-032072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-032072","line_url":"/filing/0001209191-14-032072#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":35.31,"price_display":"35.31","price_state":"stated","total_value":1059300.0,"total_display":"1,059,300.00","total_whole":"1,059,300","shares_owned_after":33000.0,"shares_owned_after_display":"33,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-08","filed_date":"2014-05-08","scope":"insider"},{"id":5554828,"accession":"0001181431-13-055811","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001181431-13-055811","line_url":"/filing/0001181431-13-055811","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":87.79161323,"price_display":"87.79","price_state":"stated","total_value":3511664.5292,"total_display":"3,511,664.53","total_whole":"3,511,665","shares_owned_after":213545.0,"shares_owned_after_display":"213,545","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-10-30","filed_date":"2013-10-31","scope":"insider","n_lines":13},{"id":4591852,"accession":"0001181431-13-045319","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001181431-13-045319","line_url":"/filing/0001181431-13-045319","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":88.5368232,"price_display":"88.54","price_state":"stated","total_value":5312209.392,"total_display":"5,312,209.39","total_whole":"5,312,209","shares_owned_after":199161.0,"shares_owned_after_display":"199,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-15","filed_date":"2013-08-16","scope":"insider","n_lines":5},{"id":3389022,"accession":"0001181431-12-020640","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-020640","line_url":"/filing/0001181431-12-020640#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":13.7352,"price_display":"13.74","price_state":"stated","total_value":13735.2,"total_display":"13,735.20","total_whole":"13,735","shares_owned_after":199061.0,"shares_owned_after_display":"199,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-29","filed_date":"2012-03-30","scope":"insider"},{"id":3374787,"accession":"0001181431-12-019176","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-019176","line_url":"/filing/0001181431-12-019176#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":13.964,"price_display":"13.96","price_state":"stated","total_value":13964.0,"total_display":"13,964.00","total_whole":"13,964","shares_owned_after":198061.0,"shares_owned_after_display":"198,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-22","filed_date":"2012-03-23","scope":"insider"},{"id":8843625,"accession":"0001181431-11-048088","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-048088","line_url":"/filing/0001181431-11-048088","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6754.0,"shares_display":"6,754","price_per_share":14.752197216464317,"price_display":"14.75","price_state":"stated","total_value":99636.34,"total_display":"99,636.34","total_whole":"99,636","shares_owned_after":197061.0,"shares_owned_after_display":"197,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-09-01","filed_date":"2011-09-06","scope":"insider","n_lines":2},{"id":9161050,"accession":"0001181431-11-044728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-044728","line_url":"/filing/0001181431-11-044728","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10065.0,"shares_display":"10,065","price_per_share":11.951058122205664,"price_display":"11.95","price_state":"stated","total_value":120287.4,"total_display":"120,287.40","total_whole":"120,287","shares_owned_after":131347.0,"shares_owned_after_display":"131,347","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-09","filed_date":"2011-08-10","scope":"insider","n_lines":2},{"id":8843464,"accession":"0001181431-11-043621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-043621","line_url":"/filing/0001181431-11-043621","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6330.0,"shares_display":"6,330","price_per_share":15.74,"price_display":"15.74","price_state":"stated","total_value":99634.2,"total_display":"99,634.20","total_whole":"99,634","shares_owned_after":121690.0,"shares_owned_after_display":"121,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-01","filed_date":"2011-08-03","scope":"insider","n_lines":2},{"id":9131759,"accession":"0001181431-11-038651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-038651","line_url":"/filing/0001181431-11-038651#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64516.0,"shares_display":"64,516","price_per_share":15.5,"price_display":"15.50","price_state":"stated","total_value":999998.0,"total_display":"999,998.00","total_whole":"999,998","shares_owned_after":181268.0,"shares_owned_after_display":"181,268","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-29","filed_date":"2011-06-29","scope":"insider"},{"id":9111979,"accession":"0001181431-11-034531","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-034531","line_url":"/filing/0001181431-11-034531","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5332.0,"shares_display":"5,332","price_per_share":18.698777194298575,"price_display":"18.70","price_state":"stated","total_value":99701.88,"total_display":"99,701.88","total_whole":"99,702","shares_owned_after":115582.0,"shares_owned_after_display":"115,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-06-01","filed_date":"2011-06-03","scope":"insider","n_lines":2},{"id":9121802,"accession":"0001181431-11-022486","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-022486","line_url":"/filing/0001181431-11-022486","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5957.0,"shares_display":"5,957","price_per_share":16.73,"price_display":"16.73","price_state":"stated","total_value":99660.61,"total_display":"99,660.61","total_whole":"99,661","shares_owned_after":110110.0,"shares_owned_after_display":"110,110","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-04","filed_date":"2011-04-05","scope":"insider","n_lines":2},{"id":7667962,"accession":"0001181431-10-062545","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-062545","line_url":"/filing/0001181431-10-062545#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":12.326,"price_display":"12.33","price_state":"stated","total_value":2465.2,"total_display":"2,465.20","total_whole":"2,465","shares_owned_after":105463.0,"shares_owned_after_display":"105,463","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-15","filed_date":"2010-12-17","scope":"insider"},{"id":7159803,"accession":"0001181431-10-052251","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-10-052251","line_url":"/filing/0001181431-10-052251#line-1","is_derivative":false,"issuer_cik":"0001314575","issuer_name":"Aegerion Pharmaceuticals, Inc.","issuer_ticker":"AEGR","issuer_name_source":null,"issuer_url":"/issuer/0001314575","owner_cik":"0001314575","owner_name":"Beer Marc D","owner_display_name":"Beer Marc D","owner_url":"/insider/0001314575","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":105263.0,"shares_display":"105,263","price_per_share":9.5,"price_display":"9.50","price_state":"stated","total_value":999998.5,"total_display":"999,998.50","total_whole":"999,999","shares_owned_after":105263.0,"shares_owned_after_display":"105,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-10-27","filed_date":"2010-10-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":45,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":26,"open_market":true},{"code":"S","label":"Open-market sale","n":19,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":45},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819253","name":"biote Corp.","url":"/issuer/0001819253","role":"Director, Officer (Executive Chairman)","n_filings":3,"first_seen":"2023-01-10","last_seen":"2026-08-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001598646","name":"Minerva Neurosciences, Inc.","url":"/issuer/0001598646","role":"Director","n_filings":1,"first_seen":"2017-03-21","last_seen":"2017-03-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001338042","name":"Aegerion Pharmaceuticals, Inc.","url":"/issuer/0001338042","role":"Director, Officer (Chief Executive Officer)","n_filings":17,"first_seen":"2010-10-27","last_seen":"2014-07-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001314575","retrieved_at":"2026-08-22T19:54:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}